• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL COSTA RICA LTD. PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL COSTA RICA LTD. PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 142540489
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/10/2023
Type of Reportable Event Malfunction
Event or Problem Description
The event involved a primary plum set, clave secondary port, 2 clave y-sites, 0.2 micron filter, secure lock, 112 inch.As per report, patient noticed during durvalumab infusion that her arm was wet.Upon further inspection, a small hole on the back of the filter at the most distal end was spurting fluid.This was not a crack, as the hole is part of every filter, however, it should not have been leaking.Infusion paused and skin dried and cleaned.Team lead was notified.She called pharmacy who made a new bag with the remaining dose that had not yet been infused (patient had received 163ml of a 305.5ml bag).A new filter line was attached below the current leaking site on the current line (which was clamped) and the new drug was ran through the new line.Medical intervention was not required.Intubation was not necessary.There were no unusual circumstances.The device was not re-sterilized or re-processed.The device was not pre-tested prior to use.Second device was not required.There was patient involvement and no patient harm.
 
Additional Manufacturer Narrative
The device has been received for evaluation.Investigation is pending.E1 initial reporter facility name: (b)(6).E1 initial reporter phone number: (b)(6).
 
Additional Manufacturer Narrative
A photo was returned by the customer showing the 0.2 micron filter.No leakage observed.Received one new 142540489 primary plum set for inspection.No damages or anomalies noted.The set was leak tested per product specifications.There was no leakage.The reported complaint was unable to be replicated or confirmed.Without the return of the used sample a comprehensive failure investigation cannot be performed, and a cause cannot be determined.The lot history was reviewed, no nonconformities were identified that may have contributed to the reported complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ICU MEDICAL COSTA RICA LTD.
zona franca global
la aurora heredia
CS 
Manufacturer Contact
reed covert
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key18317660
Report Number9615050-2023-00775
Device Sequence Number20541133
Product Code FPA
UDI-Device Identifier10887787006039
UDI-Public(01)10887787006039(17)260701(10)13684576
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K141789
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 02/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/01/2026
Device Catalogue Number142540489
Device Lot Number13684576
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/07/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/16/2023
Supplement Date Received by Manufacturer01/12/2024
Initial Report FDA Received Date12/13/2023
Supplement Report FDA Received Date02/08/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DURVALUMAB, UNK MFR.
Patient SexFemale
-
-